House Bill 4866
116th Congress(2019-2020)
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020
Active
Passed House on Sep 21, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4866
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on September 21, 2020
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Summary
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019
This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
September 22, 2020
September 21, 2020
September 17, 2020
October 28, 2019
Sort by most recent
09/22/2020
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
09/21/2020
Motion to reconsider laid on the table Agreed to without objection.
09/21/2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4616-4617)
09/21/2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
09/21/2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4866.
09/21/2020
Considered under suspension of the rules. (consideration: CR H4616-4618)
09/21/2020
Mrs. Dingell moved to suspend the rules and pass the bill, as amended.
09/17/2020
Placed on the Union Calendar, Calendar No. 413.
09/17/2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-513.
07/15/2020
Ordered to be Reported (Amended) by Voice Vote.
07/15/2020
Committee Consideration and Mark-up Session Held.
03/11/2020
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
03/11/2020
Subcommittee Consideration and Mark-up Session Held.
10/29/2019
Referred to the Subcommittee on Health.
10/28/2019
Referred to the House Committee on Energy and Commerce.
10/28/2019
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:45:07 PM